These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9861793)

  • 41. Advancing technician practice: Deliberations of a regulatory board.
    Adams AJ
    Res Social Adm Pharm; 2018 Jan; 14(1):1-5. PubMed ID: 28245969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of health care reform in Germany on the pharmacist's role in pharmacotherapy].
    Ginzelová P; Kugler KH; Solich J
    Ceska Slov Farm; 1999 Sep; 48(5):207-13. PubMed ID: 10566240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacist-patient privilege, confidentiality, and legally-mandated counseling: a legal review.
    Craft K; McBride A
    J Am Pharm Assoc (Wash); 1998; 38(3):374-8. PubMed ID: 9654868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacist's duty under OBRA-90 standards.
    Brushwood DB
    J Leg Med; 1997 Dec; 18(4):475-509. PubMed ID: 9433037
    [No Abstract]   [Full Text] [Related]  

  • 48. [Outcomes after a 2-year pharmaceutical care program for patients taking vitamin K antagonist therapy? Community pharmacist's perception].
    Mongaret C; Lepage C; Aubert L; Lestrille A; Slimano F
    Ann Pharm Fr; 2018 Mar; 76(2):114-121. PubMed ID: 29395013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medication misuse and abuse: duties and responsibilities of dispensing pharmacists.
    Berland-Benhaïm C; Giocanti D; Bartoli C; Sastre C; Leonetti G; Pelissier-Alicot A
    Med Sci Law; 2011 Jan; 51(1):49-55. PubMed ID: 21595422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacist as a member of the CPR team: evaluation by other health professionals.
    Ludwig DJ; Abramowitz PW
    Drug Intell Clin Pharm; 1983 Jun; 17(6):463-5. PubMed ID: 6861637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Iowa new practice model: Advancing technician roles to increase pharmacists' time to provide patient care services.
    Andreski M; Myers M; Gainer K; Pudlo A
    J Am Pharm Assoc (2003); 2018; 58(3):268-274.e1. PubMed ID: 29606624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-related problems identified by clinical pharmacist's students and pharmacist's interventions.
    Al-Hajje AH; Atoui F; Awada S; Rachidi S; Zein S; Salameh P
    Ann Pharm Fr; 2012 May; 70(3):169-76. PubMed ID: 22655585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacist's duty to warn.
    Cacciatore GG
    Am J Hosp Pharm; 1994 Nov; 51(22):2824-6. PubMed ID: 7856608
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacy practice developments: the potential impact on pharmacists' legal liability.
    Hattingh L; Forrester K; Smith N; Searle J
    J Law Med; 2007 Feb; 14(3):397-402. PubMed ID: 17355101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient injury and attempted link with pharmacist's negligence.
    Brushwood DB
    Am J Hosp Pharm; 1993 Nov; 50(11):2382-5. PubMed ID: 8266972
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Welty TE
    Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An essential prescription: why pharmacist-inclusive conscience clauses are necessary.
    Knestout BP
    J Contemp Health Law Policy; 2006; 22(2):349-82. PubMed ID: 17117701
    [No Abstract]   [Full Text] [Related]  

  • 58. Perspectives on the pharmacist's "product": a narrative review.
    Holdford DA
    Pharm Pract (Granada); 2021; 19(2):2430. PubMed ID: 34188731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community pharmacists' views about prescription medicine co-payments and potential implications for equitable access to medicines: a critical realist interpretation.
    Peacocke EF; Fusheini A; Norris P
    J Pharm Policy Pract; 2023 Nov; 16(1):156. PubMed ID: 38012721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community pharmacist's perspective regarding patient-centred communication in conjunction with pharmaceutical practice: A cross-sectional survey.
    Rusu A; Chereches MC; Popa C; Botezatu R; Lungu IA; Moldovan OL
    Saudi Pharm J; 2022 Sep; 30(9):1327-1344. PubMed ID: 36249938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.